HomeCompareBAX vs AVGO

BAX vs AVGO: Dividend Comparison 2026

BAX yields 2.28% · AVGO yields 0.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVGO wins by $191.9K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
AVGO
Broadcom Inc.
● Live price
0.85%
Share price
$293.41
Annual div
$2.48
5Y div CAGR
71.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$212.5K
Annual income
$28,586.09
Full AVGO calculator →

Portfolio growth — BAX vs AVGO

📍 AVGO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXAVGO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + AVGO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
AVGO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
AVGO
Annual income on $10K today (after 15% tax)
$71.84/yr
After 10yr DRIP, annual income (after tax)
$24,298.18/yr
At 15% tax rate, AVGO beats the other by $24,289.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + AVGO for your $10,000?

BAX: 50%AVGO: 50%
100% AVGO50/50100% BAX
Portfolio after 10yr
$116.6K
Annual income
$14,298.17/yr
Blended yield
12.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AVGO right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
AVGO
Analyst Ratings
52
Buy
5
Hold
Consensus: Buy
Price Target
$443.72
+51.2% upside vs current
Range: $335.00 — $510.00
Altman Z
10.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
AVGO buys
0
No recent congressional trades found for BAX or AVGO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXAVGO
Forward yield2.28%0.85%
Annual dividend / share$0.36$2.48
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%71.8%
Portfolio after 10y$20.6K$212.5K
Annual income after 10y$10.26$28,586.09
Total dividends collected$602.00$61.2K
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$19.75$443.72

Year-by-year: BAX vs AVGO ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrAVGO PortfolioAVGO Income/yrGap
1← crossover$10,866$166.33$12,985$145.21$2.1KAVGO
2$11,750$123.31$16,925$252.29$5.2KAVGO
3$12,664$90.97$22,172$440.00$9.5KAVGO
4$13,617$66.89$29,240$771.22$15.6KAVGO
5$14,619$49.07$38,905$1,360.86$24.3KAVGO
6$15,679$35.94$52,377$2,422.70$36.7KAVGO
7$16,802$26.30$71,616$4,364.05$54.8KAVGO
8$17,998$19.23$99,939$7,983.95$81.9KAVGO
9$19,272$14.05$143,229$14,907.36$124.0KAVGO
10$20,631$10.26$212,492$28,586.09$191.9KAVGO

BAX vs AVGO: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

AVGOTechnology

Broadcom, Inc. is a global technology company, which designs, develops and supplies semiconductor and infrastructure software solutions. The company is headquartered in San Jose, California and currently employs 19,000 full-time employees. The firm operates through four segments: Wired Infrastructure, Wireless Communications, Enterprise Storage, and Industrial & Other. The company offers a range of products that are used in end-products, such as enterprise and data center networking, home connectivity, set-top boxes, telecommunication equipment, smartphones, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Its product portfolio ranges from discrete devices to complex sub-systems that include multiple device types, and also includes firmware for interfacing between analog and digital systems. Its products include mechanical hardware that interfaces with optoelectronic or capacitive sensors.

Full AVGO Calculator →
📬

Get this BAX vs AVGO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAINBAX vs TXNBAX vs QCOMBAX vs ADI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.